Chris Stellatos

Corporate and Business Development at Scientia Clinical Research Ltd

Speaker

Chris Stellatos is the Director, Corporate and Business Development at Scientia and has professional with experience across the clinical research, pharmaceutical and biotechnology sectors, specialising in commercial strategy, business growth and international market development.

With close to 20 years of experience across the Asia-Pacific region, Chris brings a broad understanding of the clinical development landscape, spanning Phase I through Phase III clinical trials, with experience at both Contract Research Organisation (CRO) and clinical trial site level.

Throughout his career, Chris has worked with organisations ranging from emerging biotechnology companies and small-to-medium-sized pharmaceutical sponsors through to multinational pharmaceutical businesses.

A particular area of focus for Chris is helping international biotechnology and pharmaceutical companies navigate Australia's clinical research environment, leveraging its regulatory framework, clinical research capabilities and R&D incentives to accelerate early-phase development and support global clinical development strategies.

His expertise encompasses strategic business development, corporate development, commercial partnerships, market expansion and helping organisations translate their clinical development objectives into successful commercial outcomes.